According to a new report North America Eye Health Supplements Market, published by KBV research, the North America Eye Health Supplements Market would witness market growth of 9.3% CAGR during the forecast period (2020-2026).
The US market dominated the North America Powder Market by Country in 2019, and would continue to be a dominant market till 2026. The Canada market is experiencing a CAGR of 12.5% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 11.5% during (2020 - 2026).
The Age-related Macular Degeneration (AMD) market dominated the Canada Eye Health Supplements Market by Indication in 2019, growing at a CAGR of 10.5 % during the forecast period. The Dry Eye Syndrome market is exhibiting a CAGR of 10.9% during (2020 - 2026). Additionally, The Inflammation market would exhibit highest CAGR of 12.7% during (2020 - 2026).
The Lutein and Zeaxanthin market dominated the Mexico Eye Health Supplements Market by Ingredient Type in 2019, thereby, achieving a market value of $12.8 million by 2026. The Antioxidants market is estimated to grow at a CAGR of 9.3% during (2020 - 2026). The Flavonoids market is showcasing a CAGR of 11.8% during (2020 - 2026). Additionally, The Alpha-Lipoic Acid market is expected to witness highest CAGR of 12.2% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/north-america-eye-health-supplements-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of The Nature’s Bounty Co. (The Carlyle Group L.P.), Pfizer, Inc., Alticor Inc. (Amway Corporation), Novartis AG, Kemin Industries, Inc., ZeaVision LLC (EyePromise), EyeScience Labs, LLC, Vitabiotics Ltd., Nutrivein and NutraChamps, Inc.
By Formulation
By Indication
By Ingredient Type
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
